Planet 13 Holdings (PLNH) Free Cash Flow (2021 - 2026)
Planet 13 Holdings' (PLNH) quarterly Free Cash Flow came in at -$837994.0 in Q1 2026, up 89.37% year-on-year from -$442526.2 in Q1 2025, and up 80.85% on a QoQ basis from -$4.4 million in Q4 2025.
Planet 13 Holdings (PLNH) Free Cash Flow (2021 - 2026) Analysis & Trends
Planet 13 Holdings (PLNH) has 6 years of Free Cash Flow data on file, last reported at -$837994.0 in Q1 2026.
- On a quarterly basis, Free Cash Flow rose 89.37% year-over-year to -$837994.0 in Q1 2026; TTM through Mar 2026 was -$13.7 million, a 32.76% decrease from a year earlier, with the FY2025 full-year figure at -$20.8 million, down 203.85% from the prior year.
- Free Cash Flow for Q1 2026 stood at -$837994.0, up from -$4.4 million in the prior quarter.
- Over the last five years, Free Cash Flow for PLNH reached as high as $1.1 million in Q2 2024 and fell as low as -$14.5 million in Q2 2022.
- Historically, Free Cash Flow has averaged -$4.3 million across 5 years, with a median of -$4.0 million in 2023.
- Across the five-year window, Free Cash Flow surged 150.12% in 2024 and slumped 1300.19% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$4.0 million in 2022, then rose by 20.44% to -$3.2 million in 2023, then decreased by 24.49% to -$4.0 million in 2024, then slipped by 9.56% to -$4.4 million in 2025, then surged by 80.85% to -$837994.0 in 2026.
- Per Business Quant data, the three most recent Free Cash Flow figures were -$837994.0 in Q1 2026, -$4.4 million in Q4 2025, and -$5.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -208.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 291.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -373.37 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 363.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 348.40 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 144.40 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -38.00 Mn |
| 10 | Planet 13 Holdings | 39.35 Mn | 23.09 Mn | 9.41 Mn | -837,994.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -837,994.00 |
| Mar 31, 2026 | -837,994.00 |
| Dec 31, 2025 | -4.38 Mn |
| Dec 31, 2025 | -4.38 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Sep 30, 2025 | -5.00 Mn |
| Jun 30, 2025 | -3.50 Mn |
| Jun 30, 2025 | -3.50 Mn |
| Mar 31, 2025 | -7.88 Mn |
| Mar 31, 2025 | -7.88 Mn |
| Dec 31, 2024 | -3.99 Mn |
| Dec 31, 2024 | -3.99 Mn |
| Sep 30, 2024 | 416,858.00 |
| Sep 30, 2024 | 416,858.00 |
| Jun 30, 2024 | 1.12 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | -4.38 Mn |
| Mar 31, 2024 | -4.38 Mn |
| Dec 31, 2023 | -3.21 Mn |
| Dec 31, 2023 | -3.21 Mn |